Pulmonary fibrosis: a disease of alveolar collapse and collagen deposition

References

• Raghu G. Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada. Eur Respir J. 2017 January;49:1.
   Google Scholar
• Guo L, Karoubi G, Duchesneau P, et al. Interrupted reprogramming of alveolar type II cells induces progenitor-like cells that ameliorate pulmonary fibrosis. NPJ Regen Med. 2018;3:14.
   PubMed Web of Science ®Google Scholar
• Haschek WM, Witschi H. Pulmonary fibrosis: a possible mechanism. Toxicol Appl Pharmacol. 1979 December;51(3):475–487.
   PubMed Web of Science ®Google Scholar
• Burkhardt A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis. 1989;140:513–524.
   PubMed Web of Science ®Google Scholar
• Lutz D, Gazdhar A, Lopez-Rodriguez E, et al. Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis. Am J Respir Cell Mol Biol. 2015 February;52(2):232–243.
   PubMed Web of Science ®Google Scholar
• Myers JKA. Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest. 1988 December;94(6):1309–1311.
   PubMed Web of Science ®Google Scholar
• Katzenstein AL. Pathogenesis of fibrosis in interstitial pneumonia: an electron microscopy study. Hum Pathol. 1985 October;16(10):1015–1024.
   PubMed Web of Science ®Google Scholar
• Todd NW, Atamas SP, Luzina IG, et al. Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis. Expert Rev Respir Med. 2015 August;9(4):411–418.
   PubMed Web of Science ®Google Scholar
• Galvin JR, Frazier AA, Franks TJ. Collaborative radiologic and histopathologic assessment of fibrotic lung disease. Radiology. 2010 June;255(3):692–706.
   PubMed Web of Science ®Google Scholar
• Knudsen L, Ruppert C, Ochs M. Tissue remodeling in pulmonary fibrosis. Cell Tissue Res. 2016 March 2017 December 16;367(3): 607–626.
   PubMed Web of Science ®Google Scholar
• Johkoh T, Sakai F, Noma S, et al. Honeycombing on CT; its definition, pathologic correlation, and future direction of its diagnosis. Eur J Radiol. 2014 Jan;83(1):27–31.
   PubMed Web of Science ®Google Scholar
• Coxson HO, Hogg JC, Mayo JR, et al. Quantification of idiopathic pulmonary fibrosis using computed tomography and histology. Am J Respir Crit Care Med. 1997 May;155(5):1649–1656.
   PubMed Web of Science ®Google Scholar
• Crystal RG, Fulmer JD, Roberts WC, et al. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med. 1976 December;85(6):769–788.
   PubMed Web of Science ®Google Scholar
• Selman M, Montaño M, Ramos C, et al. Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax. 1986 May;41(5):355–359.
   PubMed Web of Science ®Google Scholar
• Fulmer JD, Bienkowski RS, Cowan MJ, et al. Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1980 August;122(2):289–301.
   PubMed Web of Science ®Google Scholar
• Lopez-Rodriguez E, Boden C, Echaide M, et al. Surfactant dysfunction during overexpression of TGF-β1 precedes profibrotic lung remodeling in vivo. Am J Physiol Lung Cell Mol Physiol. 2016 June;310(11):1260–1271.
   Web of Science ®Google Scholar
• Mai C, Verleden SE, McDonough JE, et al. Thin-section CT features of idiopathic pulmonary fibrosis correlated with micro-CT and histologic analysis. Radiology. 2017 April;283(1):252–263.
   PubMed Web of Science ®Google Scholar
• Birkelbach B, Lutz D, Ruppert C, et al. Knudsen Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial type II cells in the amiodarone mouse model. Am J Physiol Lung Cell Mol Physiol. 2015 July;309(1):63–75.
   Web of Science ®Google Scholar
• Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol. 2009;12(4):253–274.
   PubMed Web of Science ®Google Scholar
• Froese AR, Shimbori C, Bellaye PS, et al. Stretch-induced activation of transforming growth factor-β1 in pulmonary fibrosis. Am J Respir Crit Care Med. 2016 July;194(1):84–96.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang X, Hecker L, et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest. 2013 Mar;123(3):1096-1108.
   Google Scholar
• Hinz B. Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast. Proc Am Thorac Soc. 2012 July;9(3):137–147.
   PubMedGoogle Scholar
• Burgess Jeanette K, Thais M, Gavin T, et al. The extracellular matrix - the underrecognized element in lung disease? J Pathol. 2016 October;240(4):397–409.
   PubMed Web of Science ®Google Scholar
• Parker MW, Rossi D, Peterson M, et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest. 2014 April;124(4):1622–1635.
   PubMed Web of Science ®Google Scholar
• Sgalla G, Iovene B, Calvello M, et al. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018 February;19(1).
   PubMedGoogle Scholar
• Vancheri C, Failla M, Crimi N, et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010;35:496–504.
   PubMed Web of Science ®Google Scholar
• Kulkarni T, O’Reilly P, Antony VB, et al. Matrix remodeling in pulmonary fibrosis and emphysema. Am J Respir Cell Mol Biol. 2016;54:751–760.
   PubMed Web of Science ®Google Scholar
• Booth AJ, Hadley R, Cornett AM, et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med. 2012 November;186(9):866–876.
   PubMed Web of Science ®Google Scholar
• Wipff PJ, Rifkin DB, Meister JJ, et al. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007 December;179(6):1311–1323.
   PubMed Web of Science ®Google Scholar
• Goldmann WH. Mechanotransduction and focal adhesions. Cell Biol Int. 2012 July;36(7):649–652.
   PubMed Web of Science ®Google Scholar
• Liu F, Lagares D, Choi KM, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015 February;308(4):344–357.
   PubMed Web of Science ®Google Scholar
• Gabasa M, Duch P, Jorba I, et al. Epithelial contribution to the profibrotic stiff microenvironment and myofibroblast population in lung fibrosis. Mol Biol Cell. 2017 December;28(26):3741–3755.
   PubMed Web of Science ®Google Scholar
• Knipe RS, Tager AM, Liao JK. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol Rev. 2015;67(1):103–117.
   PubMed Web of Science ®Google Scholar
• Huang X, Yang N, Fiore VF, et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol. 2012 September;47(3):340–348.
   PubMed Web of Science ®Google Scholar
• Liu F, Mih JD, Shea BS, et al. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol. 2010;190(4):693–706.
   PubMed Web of Science ®Google Scholar
• Cool CD, Groshong SD, Rai PR, et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med. 2006 September;174(6):654–658.
   PubMed Web of Science ®Google Scholar
• Katzenstein AL, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol. 2008 September;39(9):1275–1294.
   PubMed Web of Science ®Google Scholar
• Kuhn C 3rd, Boldt J, King TE Jr, et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis. 1989 December;140(6):1693–1703.
   PubMedGoogle Scholar
• Kuhn CMJ. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol. 1991 May;138(5):1257–1265.
   PubMed Web of Science ®Google Scholar
• Bates JH, Davis GS, Majumdar A, et al. Linking parenchymal disease progression to changes in lung mechanical function by percolation. Am J Respir Crit Care Med. 2007 September;176(6):617–623.
   PubMed Web of Science ®Google Scholar
• Rock JR, Barkauskas CE, Cronce MJ, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A. 2011 December;108(52):1475–1483.
   PubMed Web of Science ®Google Scholar
• Alicia G, Paula D, Marta P, et al. Dysregulated collagen homeostasis by matrix stiffening and TGF-1 in fibroblasts from idiopathic pulmonary fibrosis patients: role of FAK/Akt. Int J Mol Sci. 2017 Nov 16;18(11). Pages 1-18.
   Google Scholar
• Todd NW, Jeudy J, Lavania S, et al. Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair. 2011 February;4(1).
   Google Scholar
• Yang J, Velikoff M, Canalis E, et al. Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor. Am J Physiol Lung Cell Mol Physiol. 2014 April;306(8):786–796.
   PubMed Web of Science ®Google Scholar
• Yang J, Wheeler SE, Velikoff M, et al. Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins. Am J Pathol. 2013 November;185(5):1559–1570.
   Google Scholar
• Wynn TA. Integrating mechanisms of pulmonary fibrosis. Jem. 2011 July;208(7):1339.
   PubMed Web of Science ®Google Scholar
• Chen LPM. New standards in fibrosis quantification: the value of label-free second harmonic generation. Anti-Fibrotic Drug Dev Forum November 2017. Boston USA.
   Google Scholar
• Petitjean MCL. Webinar - second harmonic generation: imaging and quantification of idiopathic pulmonary fibrosis of the lung. BioPharma Res Counc. 2016 June.
   Google Scholar
• Tilbury K, Hocker J, Wen BL, et al. Second harmonic generation microscopy analysis of extracellular matrix changes in human idiopathic pulmonary fibrosis. J Biomed Opt. 2014 August;19(8). Pages 1-8.
   PubMed Web of Science ®Google Scholar
• Win T, Screaton NJ, Porter JC, et al. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging. 2018 May;45(5):806–815.
   PubMed Web of Science ®Google Scholar
• Inchingolo R, Varone F, Sgalla G, et al. Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis. Expert Rev Respir Med. 2019 Jan;13(1):39–51.
   PubMed Web of Science ®Google Scholar
• Kolb M, Richeldi L, Behr J, et al. Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume. Thorax. 2017 April;72(4):340–346.
   PubMed Web of Science ®Google Scholar
• Guillamat-Prats R, Gay-Jordi G, Xaubet A, et al. Alveolar type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis. J Heart Lung Transplant. 2014 Jul;33(7):758–765.
   PubMed Web of Science ®Google Scholar
• Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J. 1999 Jun;13(6):1455–1476.
   PubMed Web of Science ®Google Scholar
• Mermigkis C, Bouloukaki I, Antoniou K, et al. Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath. 2015 Mar;19(1):385–391.
   PubMed Web of Science ®Google Scholar